Advertisement

Hormonal Regulation of Hepatic Cell Proliferation and Apoptosis: Implications for Carcinogenesis

  • Rolf Schulte-Hermann
  • W. Bursch
  • B. Grasl-Kraupp
  • L. Müllauer
  • H. Ochs
  • W. Parzefall
  • B. Ruttkay-Nedecky
Conference paper

Abstract

Steroid hormones have been implicated in hepatocarcinogenesis in humans and in experimental animals. The use of oral contraceptives (OC) increases the risk of adenomas and possibly carcinomas in human liver; androgenic/anabolic steroid use has also been associated with hepatic neoplastic lesions (1–4). Furthermore, a possible role of sex steroids in hepatocarcinogenesis has been suggested by the 2.0-fold increase in male: female cancer risk ratio in areas with high exposure to aflatoxin B1, or high prevalence of hepatitis B infections (5). Induction of liver tumors has been reported in rodents after prolonged treatment with relatively high doses of several estrogens and progestins. Anabolic steroids have also been shown to induce or promote tumors in rat or mouse livers (1,4, 6, 7). As to the possible mechanisms underlying these hepatocarcinogenic effects, two major hypotheses have been considered. One hypothesis presumes that sex steroids have tumor-initiating or complete carcinogenic activity. However, when sex steroids have been tested in assays for genotoxic or mutational effects, the results have been generally negative. Recently, two synthetic compounds, tamoxifen and cyproterone acetate (CPA), have been shown to have genotoxic effects, as well as initiating and complete carcinogenic activity in rat liver (8–13). Using sensitive techniques that detect DNA adducts, weak genotoxic effects have been reported for other steroids (14); however, the relevance of these weak effects is unknown. Indeed, for most steroidal hormones the “complete carcinogen” mechanism appears unlikely. The alternative hypothesis assumes a nongenotoxic mechanism for steroid carcinogenicity. In initiation/promotion studies, several steroids were found to be liver tumor promoters (7, 13, 15). Therefore, hepatocarcinogenesis may result from promotion of initiated cells formed spontaneously in the liver (16, 17).

Keywords

Ethinyl Estradiol Cyproterone Acetate Preneoplastic Cell Liver Cell Proliferation Liver Tumor Promoter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    International Agency for Research on Cancer (1987) Evaluation of carcinogenic risks to humans. IARC Monograph Suppl 7.Google Scholar
  2. 2.
    Rosenberg L (1991) The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 43:643–652.PubMedCrossRefGoogle Scholar
  3. 3.
    Tao L-C (1991) Oral contraceptive-associated liver cell adenoma and hepatocellular carcinoma. Cancer 68:341–347.PubMedCrossRefGoogle Scholar
  4. 4.
    Shimoji N, Imaida K, Hasegawa C, et al. (1990) Enhanced effect of oxymetholone, an anabolic steroid, on development of liver cell foci in rats initiated with N-diethylnitrosamine. Cancer Lett 49:165–168.PubMedCrossRefGoogle Scholar
  5. 5.
    International Agency for Research on Cancer (1993) Evaluation of carcinogenic risks to humans. IARC Monograph Vol 56.Google Scholar
  6. 6.
    Schuppler J, Schulte-Hermann R, Timmermann-Trosiener I, et al. (1982) Proliferative liver lesions and sex steroids in rats. Toxicol Pathol 10:132-144.CrossRefGoogle Scholar
  7. 7.
    Yager JD, Campbell HA, Longnecker DS, et al. (1984) Enhancement of hepatocarcinogenesis in female rats by ethinyl estradiol and mestranol but not estradiol. Cancer Res 44:3862–3869.PubMedGoogle Scholar
  8. 8.
    Neumann I, Thierau D, Andrae U, et al. (1992) Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells. Carcinogenesis 13:373–378.PubMedCrossRefGoogle Scholar
  9. 9.
    Topinka J, Andrae U, Schwarz LR, et al. (1993) Cyproterone actetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. Carcinogenesis 14:423–427.PubMedCrossRefGoogle Scholar
  10. 10.
    Demi E, Schwarz LR, Oesterle D (1993) Initiation of enzyme-altered foci by the synthetic steroid cyproterone actetate in rat liver foci. Carcinogenesis 14:1229–1231.CrossRefGoogle Scholar
  11. 11.
    Han X, Liehr JG (1992) Induction of covalent DNA adducts in rodents by tamoxifen. Cancer Res 52:1360–1363.PubMedGoogle Scholar
  12. 12.
    Hard GC, Iatropoulos MJ, Jordan K, et al. (1993) Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats. Cancer Res 53:4534–3541.PubMedGoogle Scholar
  13. 13.
    Ghia M, Mereto E (1989) Induction and promotion of gamma-glutamyltranspeptidase-positive foci in the liver of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associates. Cancer Lett 46:195–202.PubMedCrossRefGoogle Scholar
  14. 14.
    Shimomura M, Higashi S, Mizumoto R (1992) 32P-postlabeling analysis of DNA adducts in rats during estrogen-induced hepatocarcinogenesis and effect of tamoxifen on DNA adduct level. Jpn J Cancer Res 83:438–444.PubMedGoogle Scholar
  15. 15.
    Schulte-Hermann R, Schuppler J, Ohde G (1982) Effect of tumor promoters on proliferation of putative preneoplastic cells in rat liver. Carcinogenesis 7:99–104.Google Scholar
  16. 16.
    Schulte-Hermann R, Timmermann-Trosiener I, Schuppler J (1983) Promotion of spontaneous preneoplastic cells in rat liver as a possible explanation of tumor production by nonmutagenic compounds. Cancer Res 43: 839–844.PubMedGoogle Scholar
  17. 17.
    Schulte-Hermann R (1985) Tumor promotion in the liver. Arch Toxicol 57:147–158.PubMedCrossRefGoogle Scholar
  18. 18.
    Schulte-Hermann R, Parzefall W (1980) Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. I. Induction of drug-metabolizing enzymes. Chem Biol Interact 31:279–286.PubMedCrossRefGoogle Scholar
  19. 19.
    Schulte-Hermann R, Hoffmann V, Parzefall W, et al. (1980) Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. II. Induction of growth. Chem Biol Interact 31:287–300.PubMedCrossRefGoogle Scholar
  20. 20.
    Schulte-Hermann R, Hoffmann V, Landgraf H (1980) Adaptive responses of rat liver to the gestagen and anti-androgen cyproterone acetate and other inducers. III. Cytological changes. Chem Biol Interact 31:301–311.PubMedCrossRefGoogle Scholar
  21. 21.
    Ochs H, Düsterberg H, Günzel P, et al. (1986) Effect of tumor promoting contraceptive steroids on growth and drug metabolizing enzymes in rat liver. Cancer Res 46:1224–1232.PubMedGoogle Scholar
  22. 22.
    Ochs H, Düsterberg B, Schulte-Hermann R (1986) Induction of monooxygenases and growth in rat liver by progesterone. Arch Toxicol 59:146–149.PubMedCrossRefGoogle Scholar
  23. 23.
    Schulte-Hermann R, Ochs H, Bursch W, et al. (1988) Quantitative structure activity studies on effects of sixteen different steroids on growth and monooxygenases of rat liver. Cancer Res 48:2462–2468.PubMedGoogle Scholar
  24. 24.
    Schulte-Hermann R (1974) Induction of liver growth by xenobiotic compounds and other stimuli. Crit Rev Toxicol 3:97–158.CrossRefGoogle Scholar
  25. 25.
    Gerlyng P, Grotmol T, Seglen PO (1994) Effect of 4-acetylaminofluorene and other tumour promoters on hepatocellular growth and binucleation. Carcinogenesis 15:371–379.PubMedCrossRefGoogle Scholar
  26. 26.
    Parzefall W, Monschau P, Schulte-Hermann R (1989) Induction by cyproterone acetate of DNA synthesis and mitosis in primary cultures of adult rat hepatocytes in serum free medium. Arch Toxicol 63:456–461.PubMedCrossRefGoogle Scholar
  27. 27.
    Parzefall W, Erber E, Sedivy R, et al. (1991) Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. Cancer Res 51:1143–1147.PubMedGoogle Scholar
  28. 28.
    Bursch W, Lauer B, Timmermann-Trosiener I, et al. (1984) Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters. Carcinogenesis 5:453–458.PubMedCrossRefGoogle Scholar
  29. 29.
    Kerr JFR, Wyllie AH, Currie AR (1972) Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. J Cancer 26:239–257.CrossRefGoogle Scholar
  30. 30.
    Bursch W, Taper HS, Lauer B, et al. (1985) Quantitative histological and histochemical studies on the occurrence and stages of controlled cell death (apoptosis) during regression of rat liver hyperplasia. Virchows Arch 50:153–166.Google Scholar
  31. 31.
    Bursch W, Oberhammer F, Schulte-Hernann (1992) Cell death by apoptosis and its protective role against disease. Trends in Pharmacol Sei 13:245–251.CrossRefGoogle Scholar
  32. 32.
    Bursch W, Düsterberg B, Schulte-Hermann R (1986) Growth, regression and cell death in rat liver as related to tissue levels of the hepatomitogen cyproterone acetate. Arch Toxicol 59:221–227.PubMedCrossRefGoogle Scholar
  33. 33.
    Bursch W, Paffe S, Putz B, et al. (1990) Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats. Carcinogenesis 11:847–853.PubMedCrossRefGoogle Scholar
  34. 34.
    Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, et al. (1995) Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Nat Acad Sci USA, in press.Google Scholar
  35. 35.
    Bursch W, Oberhammer F, Jirtle RL, et al. (1993) Transforming growth factor pi as a signal for induction of cell death by apoptosis. Brit J Cancer 67:531–536.PubMedCrossRefGoogle Scholar
  36. 36.
    Oberhammer F, Pavelka M, Sharma S, et al. (1992) Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor-pi. Proc Natl Acad Sci USA 89:5408–5412.PubMedCrossRefGoogle Scholar
  37. 37.
    Robert AB, Lamb LC, Newton DL, et al. (1980) Transforming growth factors: Isolation of polypeptides from virally and chemically transformed cells by acid/ethanol extraction. Proc Nat Acad Sci USA 77:3494–3498.CrossRefGoogle Scholar
  38. 38.
    Schwall RH, Robbins K, Jardieu P, et al. (1993) Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 18:347–356.PubMedGoogle Scholar
  39. 39.
    Kraupp-Grasl B, Huber W, Taper H, et al. (1991) Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously. Cancer Res 51:666–671.PubMedGoogle Scholar
  40. 40.
    Schulte-Hermann R, Timmermann-Trosiener I, Barthel G, et al. (1990) DNA synthesis, apoptosis and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 50:5127–5135.PubMedGoogle Scholar
  41. 41.
    Schulte-Hermann R, Ohde G, Schuppler J, et al. (1981) Enhanced proliferation of putative preneoplastic cells in rat liver following treatment with the tumor promoters phenobarbital, hexachlorocyclohexane, steroid compounds and nafenopin. Cancer Res 41:2556–2562.PubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1996

Authors and Affiliations

  • Rolf Schulte-Hermann
  • W. Bursch
  • B. Grasl-Kraupp
  • L. Müllauer
  • H. Ochs
  • W. Parzefall
  • B. Ruttkay-Nedecky

There are no affiliations available

Personalised recommendations